Results 171 to 180 of about 10,985 (213)
Some of the next articles are maybe not open access.
Current opinion in investigational drugs (London, England : 2000), 2003
Zentaris (formerly Asta Medica) has developed and launched miltefosine, a phospholipid derivative, in various European countries [173324], [254947] and in Brazil in 1997 [332428], [366795] as a treatment for breast cancer. As of January 2002, phase III trials for treatment of leishmaniaisis were ongoing [435767].
openaire +1 more source
Zentaris (formerly Asta Medica) has developed and launched miltefosine, a phospholipid derivative, in various European countries [173324], [254947] and in Brazil in 1997 [332428], [366795] as a treatment for breast cancer. As of January 2002, phase III trials for treatment of leishmaniaisis were ongoing [435767].
openaire +1 more source
Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis
Clinical Infectious Diseases, 2021Tina Proveaux, Lauren Wetzler
exaly